Terri S Armstrong
Overview
Explore the profile of Terri S Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
5667
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McIver B, Davis T, Reinhart K, Vera E, Acquaye-Mallory A, Choi A, et al.
Cancer Med
. 2025 Mar;
14(5):e70682.
PMID: 40052556
Introduction: Symptom burden associated with interference in daily functioning is worse in those with progression or higher-grade glial tumors. This exploratory study aims to identify factors associated with its severity...
2.
Slattery K, Kauss M, Raval D, Hsieh E, Choi A, Davis T, et al.
Neurooncol Adv
. 2025 Mar;
7(1):vdaf002.
PMID: 40041201
Background: Cognitive dysfunction is common among patients with malignant glioma, yet the underlying mechanisms of this dysfunction remain unclear. Protein markers of neurodegeneration, inflammation, and vascular damage have been associated...
3.
Wright M, Miller H, Vera E, Acquaye-Mallory A, Chavis B, Choi A, et al.
Cancer Med
. 2025 Feb;
14(4):e70693.
PMID: 39953810
Introduction: Sleep disturbance (SD) and sleep-related impairment (SRI) significantly impact the lives of primary brain tumor (PBT) patients. We aimed to describe the prevalence of SD and SRI in this...
4.
King A, Roche K, Vera E, Pillai V, Polskin L, Acquaye-Mallory A, et al.
Neurooncol Pract
. 2025 Feb;
12(1):76-86.
PMID: 39917751
Background: This study explored differences in patient-reported outcomes (PROs) for patients with central nervous system (CNS) tumors during COVID, compared to pre-pandemic assessments, in light of impacted access to in-person...
5.
Gondi V, Deshmukh S, Brown P, Wefel J, Armstrong T, Tome W, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
121(2):571-572.
PMID: 39824575
No abstract available.
6.
Strauss J, Gilbert M, Mehta M, Li A, Zhou R, Ms R, et al.
Neuro Oncol
. 2024 Nov;
27(3):767-778.
PMID: 39549280
Background: Glioblastoma (GBM) is an aggressive form of brain cancer in which treatment is associated with toxicities that can result in therapy discontinuation or death. This analysis investigated clinical and...
7.
Mendoza T, King A, Vera E, Mina A, McGraw K, Pavletic S, et al.
Semin Hematol
. 2024 Nov;
61(6):457-464.
PMID: 39542751
Patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) experience a wide range of symptoms due both to their underlying disease and the effects of treatment. Designing early phase...
8.
Pascoe M, Byrne E, King A, Cooper D, Foldvary-Schaefer N, Mehra R, et al.
Neuro Oncol
. 2024 Oct;
27(1):63-76.
PMID: 39468721
Background: Radiation is the standard-of-care treatment for primary brain tumors (PBTs) but may have profound effects on sleep that have not yet been fully characterized. This systematic review aims to...
9.
Bergsneider B, Armstrong T, Conley Y, Cooper B, Hammer M, Levine J, et al.
Cancer Med
. 2024 Oct;
13(19):e70278.
PMID: 39377555
Background: Interindividual variability in oncology patients' symptom experiences poses significant challenges in prioritizing symptoms for targeted intervention(s). In this study, computational approaches were used to unbiasedly characterize the heterogeneity of...
10.
Wollet A, Rogers J, Berhanu S, Locke C, Managoli M, Wu E, et al.
Neurooncol Adv
. 2024 Oct;
6(1):vdae134.
PMID: 39359696
Background: The use of mind-body, cognitive-behavioral, and physical activity interventions have shown efficacy for improving symptom burden and functional limitations in other cancers; however, these strategies have not been widely...